ZBIO: Zenas Biopharma Inc Company Short-Term Debt
Zenas Biopharma Inc (ZBIO) specializes in developing advanced treatments for inflammatory pathologies. This price chart, which assists in the basic asset valuation, reflects the dynamics of a company striving for patent superiority through a partial B-cell depletion method, where the indicator stands at 0.00. The business is implementing dual-action antibodies for safe therapy. Process stability is ensured by a streamlined biomaterial transport system for testing.
Metric breakdowns and analytics for Zenas Corp (ZBIO)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Zenas Biopharma Inc|ZBIO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Zenas Biopharma Inc|ZBIO - Company Total Debt|Debt to Book Capitalization Ratio Zenas Biopharma Inc|ZBIO - Company Long-Term Liabilities|Company Current Liabilities Zenas Biopharma|Quick Liquidity zenasbio.com
- net income and valuation multiples indicators:
Initial company analysis:ZBIO - Zenas Biopharma
Monitoring the issuer's current solvency is critical for objective portfolio management. This indicator measures the total volume of obligations due for repayment within twelve months. Analyzing financial liabilities with a maturity of up to one year allows for an assessment of liquidity shortage risks. For Zenas Biopharma Inc (ZBIO), this parameter serves as an indicator of resilience during geopolitical conflicts. Restrictions on patent transfers between the US and China could complicate the refinancing of short-term loans.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB: Company Current Liabilities|Current Liabilities IMNM|GOSS: Company Short-Term Debts|Short-Term Debt kalvista.com (KALV)|Company Short-Term Debt Septerna|Company Short-Term Indebtedness PVLA (Pieris Pharma)|Company Short-Term Debts SVRA|Company Short-Term Debts Rigel Corp (RIGL)|Company Short-Term Debt AnaptysBio, Inc. ANAB|Short-Term Debt Volume astriatx.com (ATXS)|ENGN: Company Current Liabilities|Company Short-Term Loans and Borrowings RAPT (rapt.com)|JBIO: Company Short-Term Debts|ACRS (Aclaris Therapeutics, Inc) - Company Short-Term Debt|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|tizianalifesciences.com (TLSA) - Short-Term Debt Volume|Company Short-Term Debt Cabaletta Bio (CABA)|VTYX - Short-Term Debt|Company Short-Term Debt Theratechnologies Inc THTX|AVTX (Avalo Therapeutics Inc) - Current Liabilities|Eledon Pharmaceuticals - Company Short-Term Debts|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|CLYM: Company Short-Term Debts|zurabio.com (ZURA) - Company Short-Term Debts|Company Short-Term Debt aTyr|ADAG: Company Short-Term Loans and Borrowings|Company Short-Term Debt ImageneBio Inc (IMA)|Company Current Liabilities shattucklabs.com STTK|Company Short-Term Debts EQ (Equillium)|Company Short-Term Debts Connect Biopharma Holdings CNTB|IMUX: Company Current Liabilities|Company Short-Term Loans and Borrowings ATRA (Atara Biotherapeutics)|IFRX: Company Short-Term Debts|XFOR - Short-Term Debt Volume|Company Short-Term Debt Adicet Bio Inc.|Company Short-Term Indebtedness CELU (Celularity Corp)|Company Short-Term Debts INMB|Company Current Liabilities Barinthus Biotherapeutics Corp BRNS|Kezar Life Sciences - Company Current Liabilities|SABS (sabbiotherapeutics.com) - Current Liabilities|Akari Therapeutics Plc - Company Short-Term Debts|ENLV: Company Short-Term Debt|QTTB: Company Short-Term Debts|GOVX - Short-Term Debt Volume|Company Short-Term Debt Edesa Biotech, Inc.|Short-Term Debt ibioinc.com IBIO|Company Short-Term Debt Carisma Therapeutics (CARM)|XTLB: Current Liabilities|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Loans and Borrowings HCWB|Aptevo - Company Short-Term Debts|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|GRI Bio Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt XORTX|Company Current Liabilities Vyome Therapeutics (HIND)|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Company Current Liabilities|Company Short-Term Loans and Borrowings CALI|Affimed Therapeutics - Company Short-Term Debts|Short-Term Debt Volume Allakos Inc. ALLK|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|Company Short-Term Debts Third Harmonic Bio Inc (THRD)